Search Articles

View query in Help articles search

Search Results (1 to 10 of 9893 Results)

Download search results: END BibTex RIS


A Phase II Multicenter Trial With Rivaroxaban in the Treatment of Livedoid Vasculopathy Assessing Pain on a Visual Analog Scale

A Phase II Multicenter Trial With Rivaroxaban in the Treatment of Livedoid Vasculopathy Assessing Pain on a Visual Analog Scale

Typical clinical symptoms of livedoid vasculopathy are acute ulcerations and white scars (atrophie blanche), both of which appear concomitantly.

Attyla Drabik, Carina Hillgruber, Tobias Goerge

JMIR Res Protoc 2014;3(4):e73


The Internet Hospital Plus Drug Delivery Platform for Health Management During the COVID-19 Pandemic: Observational Study

The Internet Hospital Plus Drug Delivery Platform for Health Management During the COVID-19 Pandemic: Observational Study

As an important source of health care providers in Shenzhen, the hospital holds a great reputation in both basic clinical practice and diverse clinical research and training.

Liang Ding, Qiuru She, Fengxian Chen, Zitong Chen, Meifang Jiang, Huasi Huang, Yujin Li, Chaofeng Liao

J Med Internet Res 2020;22(8):e19678


Use of Subperiosteal Drain Versus Subdural Drain in Chronic Subdural Hematomas Treated With Burr-Hole Trepanation: Study Protocol for a Randomized Controlled Trial

Use of Subperiosteal Drain Versus Subdural Drain in Chronic Subdural Hematomas Treated With Burr-Hole Trepanation: Study Protocol for a Randomized Controlled Trial

The neurosurgical staff members undergo a trial-specific training making them eligible to include patients in the trial. A written information sheet is given to the patient or relative and as much time as necessary is allowed to discuss the options.

Jehuda Soleman, Katharina Lutz, Sabine Schaedelin, Luigi Mariani, Javier Fandino

JMIR Res Protoc 2016;5(2):e38


The Use of Aspirin to Reduce the Risk of Thrombotic Events in Patients With End-Stage Renal Disease: Protocol for a Randomized Controlled Trial

The Use of Aspirin to Reduce the Risk of Thrombotic Events in Patients With End-Stage Renal Disease: Protocol for a Randomized Controlled Trial

thrombotic events in patients with ESRD on hemodialysis without increasing the risk of major bleeding.MethodsParticipants, Interventions, and OutcomesStudy DesignWe will perform a phase 2 randomized, single-center, placebo-controlled, triple-blind, superiority clinical

Tiago Lemos Cerqueira, Armando Fartolino Guerrero, Clara Krystal Pérez Fermin, Ricardo Wang, Evelin Elfriede Balbino, Janis L Breeze, Paola Gonzalez Mego, Daniele Argentina Silva, Walid Ezzeldin Omer, Nathalie Monique Vandevelde

JMIR Res Protoc 2018;7(8):e10516